Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in Advanced Cervical Cancer
NCT00803062Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2009
- Primary completion
- Feb 2013
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of bevacizumab in Cervical Cancer (CC), sponsored by National Cancer Institute. Started Apr 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00803062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00803062.